Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Growth 2026-2032
The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.
United States market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key PET Radioisotope (Radiopharmaceuticals in PET Imaging) players cover IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Forecast” looks at past sales and reviews total world PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales in 2025, providing a comprehensive analysis by region and market sector of projected PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales for 2026 through 2032. With PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry.
This Insight Report provides a comprehensive analysis of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PET Radioisotope (Radiopharmaceuticals in PET Imaging) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PET Radioisotope (Radiopharmaceuticals in PET Imaging) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging).
This report presents a comprehensive overview, market shares, and growth opportunities of PET Radioisotope (Radiopharmaceuticals in PET Imaging) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
What factors are driving PET Radioisotope (Radiopharmaceuticals in PET Imaging) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PET Radioisotope (Radiopharmaceuticals in PET Imaging) market opportunities vary by end market size?
How does PET Radioisotope (Radiopharmaceuticals in PET Imaging) break out by Type, by Application?
PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.
United States market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key PET Radioisotope (Radiopharmaceuticals in PET Imaging) players cover IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Forecast” looks at past sales and reviews total world PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales in 2025, providing a comprehensive analysis by region and market sector of projected PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales for 2026 through 2032. With PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry.
This Insight Report provides a comprehensive analysis of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PET Radioisotope (Radiopharmaceuticals in PET Imaging) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PET Radioisotope (Radiopharmaceuticals in PET Imaging) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging).
This report presents a comprehensive overview, market shares, and growth opportunities of PET Radioisotope (Radiopharmaceuticals in PET Imaging) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 11C
- 13N
- 150
- 18F
- Others
- Medical Imaging
- Scientific Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IBA Molecular
- GE Healthcare
- Siemens Healthineers
- Eli Lilly and Company
- Mallinckrodt Pharmaceuticals
- Blue Earth Diagnostics
- ANSTO
- ROSATOM
What is the 10-year outlook for the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
What factors are driving PET Radioisotope (Radiopharmaceuticals in PET Imaging) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PET Radioisotope (Radiopharmaceuticals in PET Imaging) market opportunities vary by end market size?
How does PET Radioisotope (Radiopharmaceuticals in PET Imaging) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country/Region, 2021, 2025 & 2032
2.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Type
2.2.1 11C
2.2.2 13N
2.2.3
2.2.4 18F
2.2.5 Others
2.2.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type
2.2.6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
2.2.6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Type (2021-2026)
2.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Application
2.3.1 Medical Imaging
2.3.2 Scientific Research
2.3.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application
2.3.3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2021-2026)
2.3.3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Breakdown Data by Company
3.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Company (2021-2026)
3.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company (2021-2026)
3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Company (2021-2026)
3.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company (2021-2026)
3.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company (2021-2026)
3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Company
3.4 Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Location Distribution
3.4.2 Players PET Radioisotope (Radiopharmaceuticals in PET Imaging) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET RADIOISOTOPE (RADIOPHARMACEUTICALS IN PET IMAGING) BY GEOGRAPHIC REGION
4.1 World Historic PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Geographic Region (2021-2026)
4.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country/Region (2021-2026)
4.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Country/Region (2021-2026)
4.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Country/Region (2021-2026)
4.3 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.4 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.6 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
5 AMERICAS
5.1 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country
5.1.1 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
5.1.2 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
5.2 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
5.3 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region
6.1.1 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region (2021-2026)
6.1.2 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Region (2021-2026)
6.2 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
6.3 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country
7.1.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
7.1.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
7.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
7.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country
8.1.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
8.1.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
8.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
8.3 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
10.3 Manufacturing Process Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
10.4 Industry Chain Structure of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors
11.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customer
12 WORLD FORECAST REVIEW FOR PET RADIOISOTOPE (RADIOPHARMACEUTICALS IN PET IMAGING) BY GEOGRAPHIC REGION
12.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Forecast by Region
12.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Region (2027-2032)
12.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Type (2027-2032)
12.7 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 IBA Molecular
13.1.1 IBA Molecular Company Information
13.1.2 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 IBA Molecular Main Business Overview
13.1.5 IBA Molecular Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 Mallinckrodt Pharmaceuticals
13.5.1 Mallinckrodt Pharmaceuticals Company Information
13.5.2 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.5.5 Mallinckrodt Pharmaceuticals Latest Developments
13.6 Blue Earth Diagnostics
13.6.1 Blue Earth Diagnostics Company Information
13.6.2 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Blue Earth Diagnostics Main Business Overview
13.6.5 Blue Earth Diagnostics Latest Developments
13.7 ANSTO
13.7.1 ANSTO Company Information
13.7.2 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ANSTO Main Business Overview
13.7.5 ANSTO Latest Developments
13.8 ROSATOM
13.8.1 ROSATOM Company Information
13.8.2 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ROSATOM Main Business Overview
13.8.5 ROSATOM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country/Region, 2021, 2025 & 2032
2.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Type
2.2.1 11C
2.2.2 13N
2.2.3
2.2.4 18F
2.2.5 Others
2.2.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type
2.2.6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
2.2.6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Type (2021-2026)
2.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Application
2.3.1 Medical Imaging
2.3.2 Scientific Research
2.3.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application
2.3.3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2021-2026)
2.3.3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Breakdown Data by Company
3.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Company (2021-2026)
3.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company (2021-2026)
3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Company (2021-2026)
3.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company (2021-2026)
3.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company (2021-2026)
3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Company
3.4 Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Location Distribution
3.4.2 Players PET Radioisotope (Radiopharmaceuticals in PET Imaging) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET RADIOISOTOPE (RADIOPHARMACEUTICALS IN PET IMAGING) BY GEOGRAPHIC REGION
4.1 World Historic PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Geographic Region (2021-2026)
4.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country/Region (2021-2026)
4.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales by Country/Region (2021-2026)
4.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue by Country/Region (2021-2026)
4.3 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.4 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
4.6 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth
5 AMERICAS
5.1 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country
5.1.1 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
5.1.2 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
5.2 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
5.3 Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region
6.1.1 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region (2021-2026)
6.1.2 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Region (2021-2026)
6.2 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
6.3 APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country
7.1.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
7.1.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
7.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
7.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Country
8.1.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026)
8.1.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026)
8.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026)
8.3 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
10.3 Manufacturing Process Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
10.4 Industry Chain Structure of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors
11.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customer
12 WORLD FORECAST REVIEW FOR PET RADIOISOTOPE (RADIOPHARMACEUTICALS IN PET IMAGING) BY GEOGRAPHIC REGION
12.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Forecast by Region
12.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Region (2027-2032)
12.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Type (2027-2032)
12.7 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 IBA Molecular
13.1.1 IBA Molecular Company Information
13.1.2 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 IBA Molecular Main Business Overview
13.1.5 IBA Molecular Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 Mallinckrodt Pharmaceuticals
13.5.1 Mallinckrodt Pharmaceuticals Company Information
13.5.2 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.5.5 Mallinckrodt Pharmaceuticals Latest Developments
13.6 Blue Earth Diagnostics
13.6.1 Blue Earth Diagnostics Company Information
13.6.2 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Blue Earth Diagnostics Main Business Overview
13.6.5 Blue Earth Diagnostics Latest Developments
13.7 ANSTO
13.7.1 ANSTO Company Information
13.7.2 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ANSTO Main Business Overview
13.7.5 ANSTO Latest Developments
13.8 ROSATOM
13.8.1 ROSATOM Company Information
13.8.2 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
13.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ROSATOM Main Business Overview
13.8.5 ROSATOM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 11C
Table 4. Major Players of 13N
Table 5. Major Players of 150
Table 6. Major Players of 18F
Table 7. Major Players of Others
Table 8. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 9. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Table 10. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Type (2021-2026) & ($ million)
Table 11. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Type (2021-2026)
Table 12. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Type (2021-2026) & (US$/Ton)
Table 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale by Application (2021-2026) & (Tons)
Table 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2021-2026)
Table 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Application (2021-2026) & ($ million)
Table 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Application (2021-2026)
Table 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Application (2021-2026) & (US$/Ton)
Table 18. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Company (2021-2026) & (Tons)
Table 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company (2021-2026)
Table 20. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company (2021-2026) & ($ millions)
Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company (2021-2026)
Table 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Company (2021-2026) & (US$/Ton)
Table 23. Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producing Area Distribution and Sales Area
Table 24. Players PET Radioisotope (Radiopharmaceuticals in PET Imaging) Products Offered
Table 25. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Geographic Region (2021-2026) & (Tons)
Table 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Geographic Region (2021-2026)
Table 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country/Region (2021-2026) & (Tons)
Table 33. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2021-2026)
Table 34. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 37. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country (2021-2026)
Table 38. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 40. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 41. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region (2021-2026) & (Tons)
Table 42. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Region (2021-2026)
Table 43. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 45. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 46. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 47. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 49. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 50. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 51. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 53. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 55. Key Market Challenges & Risks of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 56. Key Industry Trends of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 57. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors List
Table 60. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customer List
Table 61. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Region (2027-2032) & (Tons)
Table 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 64. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Region (2027-2032) & (Tons)
Table 66. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Type (2027-2032) & (Tons)
Table 72. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Application (2027-2032) & (Tons)
Table 74. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. IBA Molecular Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 76. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 77. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 78. IBA Molecular Main Business
Table 79. IBA Molecular Latest Developments
Table 80. GE Healthcare Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 81. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 82. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 83. GE Healthcare Main Business
Table 84. GE Healthcare Latest Developments
Table 85. Siemens Healthineers Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 86. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 87. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 88. Siemens Healthineers Main Business
Table 89. Siemens Healthineers Latest Developments
Table 90. Eli Lilly and Company Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 92. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 93. Eli Lilly and Company Main Business
Table 94. Eli Lilly and Company Latest Developments
Table 95. Mallinckrodt Pharmaceuticals Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 96. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 97. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 98. Mallinckrodt Pharmaceuticals Main Business
Table 99. Mallinckrodt Pharmaceuticals Latest Developments
Table 100. Blue Earth Diagnostics Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 101. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 102. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 103. Blue Earth Diagnostics Main Business
Table 104. Blue Earth Diagnostics Latest Developments
Table 105. ANSTO Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 106. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 107. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 108. ANSTO Main Business
Table 109. ANSTO Latest Developments
Table 110. ROSATOM Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 111. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 112. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 113. ROSATOM Main Business
Table 114. ROSATOM Latest Developments
Table 1. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 11C
Table 4. Major Players of 13N
Table 5. Major Players of 150
Table 6. Major Players of 18F
Table 7. Major Players of Others
Table 8. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 9. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Table 10. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Type (2021-2026) & ($ million)
Table 11. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Type (2021-2026)
Table 12. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Type (2021-2026) & (US$/Ton)
Table 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale by Application (2021-2026) & (Tons)
Table 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2021-2026)
Table 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Application (2021-2026) & ($ million)
Table 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Application (2021-2026)
Table 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Application (2021-2026) & (US$/Ton)
Table 18. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Company (2021-2026) & (Tons)
Table 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company (2021-2026)
Table 20. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company (2021-2026) & ($ millions)
Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company (2021-2026)
Table 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Price by Company (2021-2026) & (US$/Ton)
Table 23. Key Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producing Area Distribution and Sales Area
Table 24. Players PET Radioisotope (Radiopharmaceuticals in PET Imaging) Products Offered
Table 25. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Geographic Region (2021-2026) & (Tons)
Table 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Geographic Region (2021-2026)
Table 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country/Region (2021-2026) & (Tons)
Table 33. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2021-2026)
Table 34. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 37. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country (2021-2026)
Table 38. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 40. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 41. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Region (2021-2026) & (Tons)
Table 42. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Region (2021-2026)
Table 43. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 45. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 46. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 47. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 49. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 50. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Country (2021-2026) & (Tons)
Table 51. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Type (2021-2026) & (Tons)
Table 53. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Application (2021-2026) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 55. Key Market Challenges & Risks of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 56. Key Industry Trends of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Table 57. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors List
Table 60. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customer List
Table 61. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Region (2027-2032) & (Tons)
Table 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 64. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Region (2027-2032) & (Tons)
Table 66. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Country (2027-2032) & (Tons)
Table 70. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Type (2027-2032) & (Tons)
Table 72. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Forecast by Application (2027-2032) & (Tons)
Table 74. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. IBA Molecular Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 76. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 77. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 78. IBA Molecular Main Business
Table 79. IBA Molecular Latest Developments
Table 80. GE Healthcare Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 81. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 82. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 83. GE Healthcare Main Business
Table 84. GE Healthcare Latest Developments
Table 85. Siemens Healthineers Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 86. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 87. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 88. Siemens Healthineers Main Business
Table 89. Siemens Healthineers Latest Developments
Table 90. Eli Lilly and Company Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 92. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 93. Eli Lilly and Company Main Business
Table 94. Eli Lilly and Company Latest Developments
Table 95. Mallinckrodt Pharmaceuticals Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 96. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 97. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 98. Mallinckrodt Pharmaceuticals Main Business
Table 99. Mallinckrodt Pharmaceuticals Latest Developments
Table 100. Blue Earth Diagnostics Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 101. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 102. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 103. Blue Earth Diagnostics Main Business
Table 104. Blue Earth Diagnostics Latest Developments
Table 105. ANSTO Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 106. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 107. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 108. ANSTO Main Business
Table 109. ANSTO Latest Developments
Table 110. ROSATOM Basic Information, PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturing Base, Sales Area and Its Competitors
Table 111. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolios and Specifications
Table 112. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 113. ROSATOM Main Business
Table 114. ROSATOM Latest Developments
LIST OF FIGURES
Figure 1. Picture of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 2. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2025)
Figure 10. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 11C
Figure 12. Product Picture of 13N
Figure 13. Product Picture of 150
Figure 14. Product Picture of 18F
Figure 15. Product Picture of Others
Figure 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type in 2026
Figure 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Type (2021-2026)
Figure 18. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumed in Medical Imaging
Figure 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Medical Imaging (2021-2026) & (Tons)
Figure 20. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumed in Scientific Research
Figure 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Scientific Research (2021-2026) & (Tons)
Figure 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2025)
Figure 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Application in 2026
Figure 24. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Company in 2026 (Tons)
Figure 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company in 2026
Figure 26. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company in 2026 ($ millions)
Figure 27. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company in 2026
Figure 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Geographic Region in 2026
Figure 30. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 31. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 32. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 33. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 34. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 35. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 38. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country in 2026
Figure 39. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Figure 40. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 41. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 42. United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Region in 2026
Figure 47. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Region (2021-2026)
Figure 48. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 49. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 50. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 54. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country in 2026
Figure 58. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Figure 59. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 60. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 61. Germany PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 62. France PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 63. UK PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 69. Egypt PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2026
Figure 75. Manufacturing Process Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 76. Industry Chain Structure of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 77. Channels of Distribution
Figure 78. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Forecast by Region (2027-2032)
Figure 79. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 2. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2025)
Figure 10. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 11C
Figure 12. Product Picture of 13N
Figure 13. Product Picture of 150
Figure 14. Product Picture of 18F
Figure 15. Product Picture of Others
Figure 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type in 2026
Figure 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Type (2021-2026)
Figure 18. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumed in Medical Imaging
Figure 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Medical Imaging (2021-2026) & (Tons)
Figure 20. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumed in Scientific Research
Figure 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Scientific Research (2021-2026) & (Tons)
Figure 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sale Market Share by Application (2025)
Figure 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Application in 2026
Figure 24. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales by Company in 2026 (Tons)
Figure 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Company in 2026
Figure 26. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Company in 2026 ($ millions)
Figure 27. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Company in 2026
Figure 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Geographic Region in 2026
Figure 30. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 31. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 32. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 33. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 34. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 35. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue 2021-2026 ($ millions)
Figure 38. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country in 2026
Figure 39. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Figure 40. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 41. Americas PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 42. United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Region in 2026
Figure 47. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Region (2021-2026)
Figure 48. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 49. APAC PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 50. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 54. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country in 2026
Figure 58. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share by Country (2021-2026)
Figure 59. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 60. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 61. Germany PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 62. France PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 63. UK PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share by Application (2021-2026)
Figure 69. Egypt PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2026
Figure 75. Manufacturing Process Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 76. Industry Chain Structure of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 77. Channels of Distribution
Figure 78. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Forecast by Region (2027-2032)
Figure 79. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue Market Share Forecast by Application (2027-2032)
